Search results

Atrial Fibrillation NETwork (AFNET)

In the Atrial Fibrillation Network, doctors and scientists work together across disciplines. Clinics and practices form a network - from family doctors to university hospitals.

Atrial Fibrillation NETwork (AFNET)

In the Atrial Fibrillation Network, doctors and scientists work together across disciplines. Clinics and practices form a network - from family doctors to university hospitals.
Digital Health

Digital Health becomes increasingly more important for the studies of AFNET regarding screening for atrial fibrillation and monitoring of patients.

Digital Health

Digital Health becomes increasingly more important for the studies of AFNET regarding screening for atrial fibrillation and monitoring of patients.
Atrial fibrillation - Information for patients

Atrial fibrillation is the most common heart rhythm disorder, especially in older people. We provide information about the current treatment options.

Atrial fibrillation - Information for patients

Atrial fibrillation is the most common heart rhythm disorder, especially in older people. We provide information about the current treatment options.

71 - 80 (153)

AFFECT-EU publication released

The desing paper of the AFFECT-EU project "Digital, risk-based screening for atrial fibrillation in the EU" has recently been published in the European Heart Journal.

Artikel

EAST-AFNET 4 @ HRS 2021

The latest results of the EAST - AFNET 4 study will be presented at this year's HRS in Boston.

Artikel

Patienten mit Vorhofflimmern und Herzschwäche profitieren von einer frühen rhythmuserhaltenden Behandlung

Pressemitteilung

Artikel

Patients with atrial fibrillation and heart failure benefit from early rhythm control

Press release

Artikel

EAST-AFNET 4 @ ESC Congress 2021

The latest results of the EAST - AFNET 4 study will be presented at this year's ESC Congress 2021 (streamed live):

Artikel

Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation

Press release

Artikel

Universitätsklinikum Augsburg

Dr. med. Michael Deiß

Kardiologie/Rhythmologie

Stenglinstr. 2

86156

Augsburg

Tel.

0821 400 2815

Fax

0821 400 3744

michael.deiss@uk-augsburg.de

https://www.uk-augsburg.de/

Leistungsspektrum

Belastungs EKG,

Cardio MRT,

Cardio MSCT,

Echokardiographie,

Elektrokardioversion,

Event Recording,

Herzkatheteruntersuchung,

Katheterablation VHF,

Kontrolle und Programmierung von Schrittmachern,

Langzeit EKG 1,

Langzeit EKG 2,

Standard EKG

Patients with first diagnosed atrial fibrillation are at high risk of cardiovascular events and suitable for early rhythm control: The EAST-AFNET 4 trial

We are pleased to present further results from the EAST-AFNET 4 trial:

Artikel

EAST – AFNET 4 Studie: Patienten mit erstmals diagnostiziertem Vorhofflimmern profitieren von frühem Rhythmuserhalt

Presseinformation

Artikel

EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control

Press release

Artikel

Atrial Fibrillation NETwork (AFNET)

Atrial Fibrillation NETwork (AFNET)

Digital Health

Digital Health

Atrial fibrillation - Information for patients

Atrial fibrillation - Information for patients

AFFECT-EU publication released

EAST-AFNET 4 @ HRS 2021

Patienten mit Vorhofflimmern und Herzschwäche profitieren von einer frühen rhythmuserhaltenden Behandlung

Patients with atrial fibrillation and heart failure benefit from early rhythm control

EAST-AFNET 4 @ ESC Congress 2021

Early rhythm control improves outcomes in patients with asymptomatic atrial fibrillation

Universitätsklinikum Augsburg

Patients with first diagnosed atrial fibrillation are at high risk of cardiovascular events and suitable for early rhythm control: The EAST-AFNET 4 trial

EAST – AFNET 4 Studie: Patienten mit erstmals diagnostiziertem Vorhofflimmern profitieren von frühem Rhythmuserhalt

EAST – AFNET 4 trial: Patients with first diagnosed atrial fibrillation (AF) benefit from early rhythm control

Research Network

Patient Information

Research

Results

Events

Ongoing trials

Contact

Career

Legal

Privacy Policy